Cardiac Biomarkers in the Identification of Future Risk in Chronic Obstructive Pulmonary Disease

E-ISSN： 1873-4294|16|14|1539-1549

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.14, 2016-06, pp. : 1539-1549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease

By Sin Don D Man S.F P.

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 1, 2005-01 ,pp. : 8-13

NRC Research Press

Access to resources Recommend Favorite

The risk/benefit of inhaled corticosteroids in chronic obstructive pulmonary disease

By Bonay Marcel Bancal Catherine Crestani Bruno

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 251-271

Informa Healthcare

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite

Roflumilast: In Chronic Obstructive Pulmonary Disease

By Sanford Mark

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1615-1627

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of chronic obstructive pulmonary disease

By Hizawa Nobuyuki

Pharmacogenomics, Vol. 14, Iss. 10, 2013-07 ,pp. : 1215-1225

Future Medicine

Access to resources Recommend Favorite